New US Food and Drug Administration (FDA) draft guidance addresses when and how to evaluate drugs for the potential to impair driving ability, an issue that arises during agency reviews of approved and ivestigational products. Megan Auderset, writer and editor from Thomson Reuters shares her thoughts on the FDA’s recommendations on drug testing.